UpScriptHealth

News

Eversana, UpScriptHealth ally on digital patient platform

UpScriptHealth has joined forces with Eversana on a digital platform that aims to improve patient access to therapies, and the experience that goes with it.

News

Rhapsido is first drug cleared for chronic hives disorder SD

Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks